A Study to Examine the Effects of an Experimental Drug on Women With Breast Cancer and Metastatic Bone Disease (MBD)(0822-016)(COMPLETED)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Metastatic Bone Disease
Interventions: DRUG: ZA|DRUG: Odanacatib|DRUG: Odanacatib matching placebo|DRUG: ZA matching placebo
Sponsor: Merck Sharp & Dohme LLC